FIELD: medicine.
SUBSTANCE: cecum lymphoma is modelled by the introduction of 2,4,6-trinitrobenzosulfonic acid to a rat in a dose of 0.1-0.15 ml, diluted in 0.1-0.15 ml of a 50% ethanol solution. Introduction is realised into a submucosal layer of the cecum cupola 2-3-times daily for 2-3 weeks.
EFFECT: creation of an adequate model of the cecum lymphoma.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SIMULATING SERRATED COLON ADENOMA | 2014 |
|
RU2562878C1 |
METHOD FOR SIMULATING UTERINE FIBROID | 2014 |
|
RU2561000C1 |
METHOD OF TREATING DIVERTICULOSIS IN EXPERIMENT | 2011 |
|
RU2454730C1 |
METHOD FOR CLEAR CELL RENAL CANCER SIMULATION | 2016 |
|
RU2615860C1 |
METHOD FOR CARCINOID SYNDROME SIMULATION | 2015 |
|
RU2633266C2 |
METHOD FOR DETERMINING INDICATIONS FOR THERAPY OF POSTOPERATIVE GASTROINTESTINAL ANASTOMOTIC STENOSIS | 2013 |
|
RU2543291C2 |
METHOD FOR MODELING NONSPECIFIC ULCERATIVE COLITIS CASES | 2006 |
|
RU2316055C1 |
METHOD OF DIAGNOSING POSTOPERATIVE STENOSES OF GASTROINTESTINAL TRACT IN EXPERIMENT | 2012 |
|
RU2495618C1 |
METHOD FOR ENTERO- AND PANCREACTOPROTECTIVE ACTION OF NON-STEROID ANTI-INFLAMMATORY PREPARATIONS | 2012 |
|
RU2545446C2 |
METHOD OF SYSTEMIC FIBROSIS MODELLING | 2008 |
|
RU2371778C1 |
Authors
Dates
2015-06-10—Published
2014-05-19—Filed